Related Experiment Videos
The effect of dexmedetomidine on nutrient organ blood flow
C J Lawrence1, F W Prinzen, S de Lange
1Department of Anesthesiology, University Hospital Maastricht, The Netherlands.
Abstract:
The alpha 2-adrenergic agonist dexmedetomidine decreases not only heart rate, myocardial contractility, and oxygen demand, but also cardiac output (Q). To investigate whether this reduction in Q could critically impair perfusion of individual organs, we studied the effect of dexmedetomidine on nutrient blood flow to the heart, brain, kidney, spleen, skin, intestine, liver, and arteriovenous anastomoses using the radioactive microsphere technique. Studies were conducted in 14 dogs with an open chest and anesthetized with either chloralose/urethane (CU) or fentanyl/halothane (FH), to create different baseline conditions. Hemodynamic variables, organ blood flow, arterial and mixed venous oxygen, and lactate content were measured before and after administration of 0.1, 1, and 10 micrograms/kg dexmedetomidine intravenously (IV). After 10 micrograms/kg dexmedetomidine Q decreased in both groups by 50%. The decrease in blood flow varied greatly between the organs. While flow through arteriovenous anastomoses and skin decreased by 70% to 90%, renal blood flow decreased by 30%, cerebral blood flow only when baseline blood flow was high (FH dogs), and left ventricular blood flow only in the CU group, where the largest decrease in hemodynamic variables occurred. Oxygen consumption decreased only in CU dogs, but so did arterial lactate levels. These data indicate that dexmedetomidine causes considerable redistribution of Q, predominantly reducing blood flow to less vital organs and shunt flow.
Insights
Dexmedetomidine, an alpha 2-adrenergic agonist, significantly reduces cardiac output (Q) and redistributes blood flow. It prioritizes vital organs, decreasing flow to less critical areas like skin and arteriovenous anastomoses.
Area of Science:
- Cardiovascular Physiology
- Pharmacology
- Anesthesiology
Background:
- Dexmedetomidine is an alpha 2-adrenergic agonist known to reduce cardiac output (Q).
- The impact of dexmedetomidine-induced Q reduction on organ-specific blood flow requires detailed investigation.
Purpose of the Study:
- To evaluate the effects of dexmedetomidine on nutrient blood flow distribution to various organs.
- To determine if dexmedetomidine critically impairs perfusion in specific organs.
Main Methods:
- Utilized the radioactive microsphere technique in 14 dogs under different anesthetic conditions (chloralose/urethane or fentanyl/halothane).
- Measured hemodynamic variables, organ blood flow, and oxygen/lactate levels before and after intravenous dexmedetomidine administration (0.1, 1, 10 µg/kg).
Main Results:
- A 10 µg/kg dose of dexmedetomidine decreased cardiac output (Q) by 50% in both anesthetic groups.
- Blood flow reduction varied significantly by organ: arteriovenous anastomoses and skin (70-90%), kidneys (30%), brain (only in FH dogs with high baseline flow), and left ventricle (only in CU dogs).
- Oxygen consumption and arterial lactate levels decreased only in the chloralose/urethane group.
Conclusions:
- Dexmedetomidine causes a substantial redistribution of cardiac output (Q).
- The drug preferentially reduces blood flow to less vital organs and shunt pathways.
- Organ perfusion is differentially affected by dexmedetomidine, depending on the organ's importance and baseline conditions.